AstraZeneca vaccine has major role to play, lead South Africa investigator says

JOHANNESBURG (Reuters) - The lead investigator on the South African trial of AstraZeneca's vaccine said he believed the vaccine had a major role to play in Africa and globally, despite data showing it offered minimal protection against mild-to-moderate COVID-19 disease by the country's dominant virus variant. Shabir Madhi from the University of the Witwatersrand in Johannesburg told Reuters he would begin rolling out the 1 million AstraZeneca doses already in the country immediately, since they have an expiry date in April and it would be reckless to waste them. South African health officials said on Sunday that they were putting AstraZeneca vaccinations on hold temporarily while they sought scientific advice on how to proceed

Reuters February 09, 2021 00:10:22 IST
AstraZeneca vaccine has major role to play, lead South Africa investigator says

AstraZeneca vaccine has major role to play lead South Africa investigator says

JOHANNESBURG (Reuters) - The lead investigator on the South African trial of AstraZeneca's vaccine said he believed the vaccine had a major role to play in Africa and globally, despite data showing it offered minimal protection against mild-to-moderate COVID-19 disease by the country's dominant virus variant.

Shabir Madhi from the University of the Witwatersrand in Johannesburg told Reuters he would begin rolling out the 1 million AstraZeneca doses already in the country immediately, since they have an expiry date in April and it would be reckless to waste them.

South African health officials said on Sunday that they were putting AstraZeneca vaccinations on hold temporarily while they sought scientific advice on how to proceed. Vaccinations had been due to start soon, after the first vaccine doses arrived by plane from India last week.

(Reporting by Alexander Winning; Editing by Alison Williams)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Robinhood now a go-to for young investors and short sellers
Business

Robinhood now a go-to for young investors and short sellers

By John McCrank NEW YORK (Reuters) - Robinhood, the online brokerage used by many retail traders to pile in to heavily shorted stocks like GameStop Corp, has made an ambitious push into loaning out its clients' shares to short sellers as it expands its business. The broker had $1.9 billion in shares loaned out as of Dec. 31, nearly three times the $674 million a year earlier, and it was permitted to lend out $4.6 billion worth of securities under margin agreements, around five times bigger than the prior year, according to an annual regulatory filing late on Monday

Wall Street mixed as Apple and Tesla retreat
Business

Wall Street mixed as Apple and Tesla retreat

By Noel Randewich (Reuters) - Wall Street was mixed on Tuesday, with Apple and Tesla losing ground, while materials and energy companies climbed as investors looked toward the U.S. Congress approving another stimulus package.

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures
Business

Biden's SEC nominee vows review of GameStop trading issues, climate disclosures

By Pete Schroeder and Chris Prentice WASHINGTON (Reuters) - U.S. President Joe Biden's pick to head a key market regulator promised on Tuesday a thorough review of issues raised by the GameStop Corp stock frenzy and suggested companies may have to disclose their potential risks from climate change